ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2022
|
|
Luvit123
|
32 |
11K |
15 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
32
|
11K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
9 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
3 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Investor Briefing Invitation - June 2022 Quarter
|
|
Luvit123
|
9 |
6.2K |
12 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
9
|
6.2K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
10 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2022
|
|
Luvit123
|
32 |
11K |
15 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
32
|
11K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
Luvit123
|
58 |
25K |
1 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
58
|
25K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
Luvit123
|
58 |
25K |
4 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
58
|
25K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: SubB2M US Patent Grant and Program Update
|
|
Luvit123
|
21 |
10K |
14 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
21
|
10K
|
14
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: IIQ Investor Presentation
|
|
Luvit123
|
74 |
36K |
1 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
74
|
36K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
VA Health Care Speech Biden Today
|
|
Luvit123
|
5 |
2.9K |
13 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
5
|
2.9K
|
13
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: IIQ Investor Presentation
|
|
Luvit123
|
74 |
36K |
2 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
74
|
36K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: IIQ Investor Presentation
|
|
Luvit123
|
74 |
36K |
8 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
74
|
36K
|
8
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: IIQ Investor Presentation
|
|
Luvit123
|
74 |
36K |
9 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
74
|
36K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ&University of Sydney Present New EXO-NET Data at ISEV
|
|
Luvit123
|
11 |
6.6K |
6 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
11
|
6.6K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Change of Director's Interest - Philip Powell
|
|
Luvit123
|
12 |
6.3K |
12 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
12
|
6.3K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
6 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Update on Legal Proceedings and BARD1 Autoantibody Program
|
|
Luvit123
|
56 |
26K |
9 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
56
|
26K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Update on Legal Proceedings and BARD1 Autoantibody Program
|
|
Luvit123
|
56 |
26K |
4 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
56
|
26K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
5 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
0 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
Luvit123
|
22 |
10K |
1 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
22
|
10K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
8 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Timing the market 4dx
|
|
Luvit123
|
206 |
65K |
12 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
206
|
65K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Timing the market 4dx
|
|
Luvit123
|
206 |
65K |
5 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
206
|
65K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
Luvit123
|
22 |
10K |
8 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
22
|
10K
|
8
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
Luvit123
|
22 |
10K |
10 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
22
|
10K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
Luvit123
|
22 |
10K |
12 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
22
|
10K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
14 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
14
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
Luvit123
|
211 |
73K |
1 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
211
|
73K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
Luvit123
|
211 |
73K |
8 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
211
|
73K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Timing the market 4dx
|
|
Luvit123
|
206 |
65K |
12 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
206
|
65K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
1 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Timing the market 4dx
|
|
Luvit123
|
206 |
65K |
4 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
206
|
65K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Awarded Additional BTB Funding to Develop SubB2M test
|
|
Luvit123
|
21 |
10K |
8 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
21
|
10K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
6 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
New name change of fortune
|
|
Luvit123
|
23 |
15K |
1 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
23
|
15K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Completion of first commercial scans at I-MED
|
|
Luvit123
|
34 |
9.9K |
4 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
34
|
9.9K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Completion of first commercial scans at I-MED
|
|
Luvit123
|
34 |
9.9K |
8 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
34
|
9.9K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical presents at BP Healthcare Conference
|
|
Luvit123
|
93 |
21K |
3 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
93
|
21K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
1 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
under $1 ? R you kidding me?
|
|
Luvit123
|
48 |
19K |
28 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
48
|
19K
|
28
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
Luvit123
|
1.4K |
556K |
1 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
1.4K
|
556K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
4 |
09/10/21 |
09/10/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
Luvit123
|
252 |
104K |
9 |
02/10/21 |
02/10/21 |
ASX - By Stock
|
252
|
104K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
Luvit123
|
252 |
104K |
13 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
252
|
104K
|
13
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
Luvit123
|
252 |
104K |
8 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
252
|
104K
|
8
|
|
ASX - By Stock
|
IIQ |
Re:
Galleri Test
|
|
Luvit123
|
4 |
1.8K |
9 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
4
|
1.8K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
Luvit123
|
1.4K |
556K |
19 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
1.4K
|
556K
|
19
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
5 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
5
|
|